NCT01174888 Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia Status COMPLETED Phase PHASE1
NCT01170598 Acute Myeloid Leukaemia (AML) Patients Undergoing Induction Chemotherapy Status COMPLETED Phase PHASE2
NCT01169012 PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias Status COMPLETED Phase PHASE1
NCT01168219 Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia Status COMPLETED Phase PHASE2
NCT01163201 T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies Status WITHDRAWN Phase PHASE1/PHASE2
NCT01149408 Decitabine Maintenance in Elderly Acute Myeloid Leukemia Patients Status COMPLETED Phase PHASE1
NCT01146977 Autologous Hematopoietic Cell Transplantation for Core-binding Factor (CBF) Acute Myeloid Leukemia (AML) in the First Complete Remission (CR1) Status UNKNOWN Phase PHASE2
NCT01142375 Development and Exploration of the Feasibility of Using Locally Synthesized Small Molecule Inhibitors to Treat Human Acute Leukemia Cells Status UNKNOWN Phase N/A
NCT01141673 Development of a Diagnostic Kit for FLT3-ITD in Acute Myeloid Leukemia Status UNKNOWN Phase N/A
NCT01141543 Feasibility and Efficiency Study of Leukemic Cell Mobilization With Plerixafor Injection Status COMPLETED Phase N/A
NCT01139970 Veliparib and Temozolomide in Treating Patients With Acute Leukemia Status COMPLETED Phase PHASE1
NCT01133886 Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) Failure Status UNKNOWN Phase PHASE2
NCT01130662 Combination of Decitabine and Midostaurin in Patients Older Than 60 With Newly Diagnosed or Relapsed Refractory Acute Myeloid Leukemia Status COMPLETED Phase PHASE1
NCT01110824 Prevention of Left Ventricular Dysfunction During Chemotherapy Status COMPLETED Phase PHASE3
NCT01075425 Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome Status COMPLETED Phase PHASE1
NCT01074047 Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE3
NCT01068301 A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation Status COMPLETED Phase PHASE1
NCT01067274 ALFA-0703 Study in Older Patients With Acute Myeloblastic Leukemia (AML) Status WITHDRAWN Phase PHASE3
NCT01066494 A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML) Status UNKNOWN Phase PHASE2
NCT01065545 The Role of Maintenance Oral Clofarabine in Older Adults With Acute Myeloid Leukemia Status WITHDRAWN Phase PHASE1